» Articles » PMID: 34093504

A Nitric Oxide-Responsive Transcriptional Regulator NsrR Cooperates With Lrp and CRP to Tightly Control the Gene in

Overview
Journal Front Microbiol
Specialty Microbiology
Date 2021 Jun 7
PMID 34093504
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Nitric oxide (NO) is an important antimicrobial effector produced by the host innate immune system to counteract invading pathogens. To survive and establish a successful infection, a fulminating human pathogen expresses the gene encoding an NO dioxygenase in an NO-responsive manner. In this study, we identified an Rrf2-family transcriptional regulator NsrR that is predicted to contain the Fe-S cluster coordinated by three cysteine residues. Transcriptome analysis showed that NsrR controls the expression of multiple genes potentially involved in nitrosative stress responses. Particularly, NsrR acts as a strong repressor of transcription and relieves the repression of upon exposure to NO. Notably, and are transcribed divergently, and their promoter regions overlap with each other. Molecular biological analyses revealed that NsrR directly binds to this overlapping promoter region, which is alleviated by loss of the Fe-S cluster, leading to the subsequent derepression of under nitrosative stress. We further found that a leucine-responsive regulatory protein (Lrp) negatively regulates in an NsrR-dependent manner by directly binding to the promoter region, presumably resulting in a DNA conformation change to support the repression by NsrR. Meanwhile, a cyclic AMP receptor protein (CRP) positively regulates probably through repression of and by directly binding to each promoter region in a sequential cascade. Altogether, this collaborative regulation of NsrR along with Lrp and CRP enables an elaborate control of transcription, contributing to survival under host-derived nitrosative stress and thereby the pathogenesis of .

Citing Articles

Two novel genes identified by large-scale transcriptomic analysis are essential for biofilm and rugose colony development of Vibrio vulnificus.

Lee H, Im H, Hwang S, Ko D, Choi S PLoS Pathog. 2023; 19(1):e1011064.

PMID: 36656902 PMC: 9888727. DOI: 10.1371/journal.ppat.1011064.


Nitric Oxide Signaling for Aerial Mycelium Formation in Streptomyces coelicolor A3(2) M145.

Honma S, Ito S, Yajima S, Sasaki Y Appl Environ Microbiol. 2022; 88(23):e0122222.

PMID: 36354316 PMC: 9746327. DOI: 10.1128/aem.01222-22.


S-Nitrosylation of the virulence regulator AphB promotes Vibrio cholerae pathogenesis.

Chen J, Byun H, She Q, Liu Z, Ruggeberg K, Pu Q PLoS Pathog. 2022; 18(6):e1010581.

PMID: 35714156 PMC: 9246220. DOI: 10.1371/journal.ppat.1010581.


Transcriptomic Analysis Reveals That Municipal Wastewater Effluent Enhances Growth and Virulence Potential.

Correa Velez K, Norman R Front Microbiol. 2021; 12:754683.

PMID: 34759904 PMC: 8573347. DOI: 10.3389/fmicb.2021.754683.

References
1.
Cho B, Barrett C, Knight E, Park Y, Palsson B . Genome-scale reconstruction of the Lrp regulatory network in Escherichia coli. Proc Natl Acad Sci U S A. 2008; 105(49):19462-7. PMC: 2614783. DOI: 10.1073/pnas.0807227105. View

2.
Choi H, Park N, Kim D, Chung H, Ryu S, Choi S . Promoter analysis and regulatory characteristics of vvhBA encoding cytolytic hemolysin of Vibrio vulnificus. J Biol Chem. 2002; 277(49):47292-9. DOI: 10.1074/jbc.M206893200. View

3.
Rhee J, Kim K, Choi S . Activation of the Vibrio vulnificus cadBA Operon by Leucine-responsive regulatory protein is mediated by CadC. J Microbiol Biotechnol. 2008; 18(11):1755-61. DOI: 10.4014/jmb.0800.121. View

4.
Stewart V, Bledsoe P, Chen L, Cai A . Catabolite repression control of napF (periplasmic nitrate reductase) operon expression in Escherichia coli K-12. J Bacteriol. 2008; 191(3):996-1005. PMC: 2632075. DOI: 10.1128/JB.00873-08. View

5.
Nurhasni H, Cao J, Choi M, Kim I, Lee B, Jung Y . Nitric oxide-releasing poly(lactic-co-glycolic acid)-polyethylenimine nanoparticles for prolonged nitric oxide release, antibacterial efficacy, and in vivo wound healing activity. Int J Nanomedicine. 2015; 10:3065-80. PMC: 4411019. DOI: 10.2147/IJN.S82199. View